Copy of `AGNIC - Wildlife terms`
The wordlist doesn't exist anymore, or, the website doesn't exist anymore. On this page you can find a copy of the original information. The information may have been taken offline because it is outdated.
|
|
AGNIC - Wildlife terms
Category: Animals and Nature > Wildlife Management
Date & country: 27/09/2013, USA Words: 917
|
ifnsee interferon.
igimmunoglobulin; see antibody.
il28bsee interleukin 28B
immune clearanceA phase of chronic HBV that is marked by increased levels of ALT and HBV DNA (viral load). During this phase there is more damage occurring in the liver.
immune globulinsee antibody.
immune responsethe activity of the immune system, for example against an outside invader (e.g., bacteria, virus), cancerous cells, or the body's own tissues (autoimmune response).
immune systemthe body's defense system that protects against foreign invaders (e.g., bacteria, viruses). Some immune defenses are nonspecific (e.g., phagocytosis), while others are directed against specific invaders (e.g., antibody production). Organs of the immune system include the lymph nodes, spleen, thymus, and tonsils.
immune tolerantA phase of chronic HBV when HBV DNA levels are high, but ALT levels are low. This indicates that there is little liver damage occurring.
immunityresistance to disease; the body's ability to recognize and defend against outside invaders and cancerous cells. Immunity may be either natural or acquired (for example, artificially induced through a vaccine).
immunizationthe process by which a person is protected against illness caused by a pathogen (e.g., bacteria, virus). Active immunization (vaccination) involves exposing a person to antigens to prompt the body to mount an immune response (e.g., production of antibodies). Passive immunization involves the injection of an antibody preparation (e.g., gamma globulin).
immunocompetentcapable of mounting an immune response.
immunocompromisesee immunodeficiency.
immunodeficiencyinability of the immune system to work properly, resulting in increased susceptibility to disease.
immunoglobulinsee antibody.
immunomodulatoran agent that influences the body's immune response.
immunosuppressionsee immunodeficiency.
immunosuppressivea drug or other agent that decreases immune system function.
impdh inhibitorsee inosine monophosphate dehyrogenase inhibitor.
in uteroin the uterus; refers to events that occur in the womb before birth.
inactive carrierA phase of chronic HBV that is marked by low HBV DNA, and ALT levels indicating less damage occurring in the liver.
incidence (also incidence rate)the number of new cases of a disease or condition in a specific population during a given period of time. The incidence rate is determined by dividing the number of new cases by the total population. Contrast with prevalence.
incivek (generic name telaprevir)an HCV protease inhibitor (taken in combination with pegylated interferon plus ribavirin) approved by the FDA to treat people with HCV genotype 1.
inclusion criteriaconditions that a person must meet in order to be eligible for a clinical trial. Contrast with exclusion criteria.
incubation periodthe period of time between initial exposure to an infectious microorganism and the development of disease symptoms.
indacronym for Investigational New Drug.
induction therapythe initiation phase of a particular treatment. Typically induction therapy uses higher or more frequent doses of a drug. Contrast with maintenance therapy.
infectiona condition in which the body is invaded by an infectious organism (e.g., bacteria, virus, fungus).
infectiousa disease or condition that can be transmitted from one person to another.
infectious hepatitissee hepatitis A.
infergenbrand name of interferon alfacon 1 consensus interferon, distributed by Kadmon Pharmaceuticals.
inflammationthe body's response to tissue injury or infection, typically characterized by redness, swelling, heat, and pain.
informed consenta mechanism designed to protect subjects in clinical trials. Before entering a trial, participants must sign a form stating that they have been given and understand important information about the trial (including possible risks and benefits) and voluntarily agree to take part.
infusiondirect injection (e.g., of a drug, nutrients) into the bloodstream.
inhibitoran agent that inhibits or blocks an activity.
injection drug user (idu)a person who uses an illegal drug (e.g., heroin, cocaine) administered with a needle and syringe. The terms intravenous drug user (IVDU) and people who inject drugs (PWID) are also sometimes used.
insomniainability to sleep.
insulin resistancea condition in which the body's tissues cannot properly use insulin, leading to blood sugar imbalances.
intent-to-treat analysisa method of analyzing the results of a clinical trial in which all participants who were originally assigned to an arm are analyzed, including those who dropped out due to treatment failure or side effects. Contrast with as-treated analysis.
interferon (ifn)a cytokine (messenger protein) that plays a role in immune response. The three major classes of interferon are alpha, beta, and gamma.
interferon-alphaa naturally occurring protein produced by the immune system that interferes with viral replication. Interferon-alpha (brand names include Intron-A, Roferon-A) is standard treatment for HCV and is also approved for HBV. Side effects may include flu-like symptoms, fatigue, loss of appetite, depression, and anxiety.
interleukin (il)a cytokine (chemical messenger), secreted by immune system blood cells, that regulates a range of immune functions.
interleukin 28b (il28b) a variation of interleukin that directs an immune response to the hepatitis C virus. IL28B is categorized into genotypes CC, TT, and C/T. IL28B CC genotype produces that strongest immune response against hepatitis C.
international unit (iu)a standard unit of measurement.
intoleranceinability of the body to tolerate a drug, resulting in adverse side effects.
intracellularwithin a cell.
intravenous (iv)injected directly into a vein.
intravenous immunoglobulin (ivig)an antibody preparation administered intravenously to treat illness in a person whose own immune system does not produce sufficient antibodies.
intron-abrand name of interferon-alpha-2b, produced by Schering-Plough.
investigational new drug (ind)an FDA classification for experimental drugs that are undergoing clinical trials to assess their safety and effectiveness prior to marketing approval.
investigatora clinical researcher who is involved with a clinical trial protocol and its implementation. The Principal Investigator is ultimately responsible for the conduct of the trial.
ires inhibitorsee internal ribosome entry site inhibitor.
ironan important trace element needed for the production of hemoglobin in red blood cells. High levels of iron can be toxic to the liver.
iron-deficiency anemiathe most common type of anemia, caused by a lack of iron.
ischemiareduced blood supply to bodily tissues.
islet cella cell in the Islets of Langerhans in the pancreas that produces insulin.
iusee international unit.
ivsee intravenous.
ivdusee injection drug user.
ivigsee intravenous immunoglobulin
kayser-fleischer ringssee Wilson
ketonea byproduct of fat metabolism. When the body does not have enough glucose, the liver converts fatty acids into ketones, which are used as fuel by the muscles.
kidney stone (nephrolithiasis)an accumulation of substances (e.g., drug crystals, minerals) in the kidneys, leading to blockage and pain.
kupffer cella type of macrophage that resides in the liver and ingests bacteria absorbed from the intestines.
lactationproduction of breast milk.
lamivudine (brand name epivir-hbv)A nucleoside analogue medicine used to treat chronic hepatitis B and HIV produced by GlaxoSmithKline. Lamivudine is not recommended as a first line of HBV treatment because of the high rate of drug resistance.
laparoscopic liver biopsya type of liver biopsy using a laparoscope.
laparoscopya procedure in which a lighted instrument is inserted through an abdominal incision for the purpose of diagnosis, biopsy, or surgery.
laxativean agent that promotes bowel evacuation (defecation).
lecithina fatty compound required for proper metabolism.
lesiona tissue injury or wound.
leukinesee granulocyte-macrophage colony-stimulating factor.
leukocytean immune system white blood cell (e.g., T-cell, B-cell, neutrophil).
lichen planusan inflammatory disease of the skin and mucous membranes characterized by red or purple bumps or blotches. The cause of lichen planus is not known, but it appears to be an autoimmune condition.
lipida fat.
lipodystrophya syndrome that involves abnormal lipid metabolism and redistribution of body fat.
lipogenesisproduction of lipids (fats).
livera large organ on the upper right side of the abdomen that plays an important role in the metabolism of sugars and fats, synthesizes several proteins, and filters toxins from the blood.
liver biopsya medical procedure that removes a piece of liver tissue which is then examined under a microscope for inflammation and damage.
liver cancermalignant proliferation of cells in the liver. The most common type of liver cancer in people with chronic hepatitis is hepatocellular carcinoma.
liver cellsee hepatocyte.
liver enzymesee aminotransferase.
living donora person who donates an organ or part of an organ while alive to another person.
lobeone of the four anatomical divisions of the liver; lobes are further divided into lobules.
lobule of livera structural unit consisting of hepatic (liver) cells shaped like a hexagon with six portal triads surrounding a central vein.
loga measure based on the logarithmic scale that refers to quantities in factor of ten. A log change is an exponential, or 10-fold, increase or decrease (e.g., a change from 10 to 100 is a 1-log increase; a change from 1,000,000 to 10,000 is a 2-log decrease). Viral load is sometimes expressed in logs.
lupussee systemic lupus erythematosus.
lymph node (lymph gland)a small, bean-sized organ located throughout the body, with concentrations in the neck, groin, and armpits. Lymph nodes filter out antigens and are the site of immune cell activation.
lymphatic systema network of organs and vessels that help maintain the fluid environment of the body and coordinate immune responses. The lymphoid organs include the lymph nodes, spleen, thymus, tonsils, and adenoids.
lymphocytea type of white blood cell (e.g., T-cell, B-cell, natural killer cell) that plays a role in the body's immune defense.
lymphocytopeniaa deficiency of lymphocytes.
macrophagea large scavenger white blood cell that ingests and processes foreign invaders and cellular debris. Specialized macrophages protect the skin, lungs (alveolar macrophages), brain (microglia), liver (Kupffer cells), and other tissues.
magnetic resonance imaging (mri)a sensitive, non-invasive method for viewing soft tissues of the body using a magnetic field.
maintenance therapytherapy that follows successful initial treatment of an illness; generally maintenance therapy continues for a long period of time (possibly for life) to prevent disease recurrence. Contrast with induction therapy.
malaisea generalized feeling of illness and discomfort; a flu-like feeling.
malignancya cancer, neoplasm, or tumor that grows in an uncontrolled manner, and may invade nearby tissue and metastasize, or spread, to other areas of the body.
malignanta condition that is severe, harmful, or resistant to treatment. Contrast with benign.
malnutritionlack of the minimum amount of nutrients (proteins, carbohydrates, lipids, vitamins, minerals, etc.) necessary for good health. Malnutrition may result from poor diet, lack of appetite, or inadequate absorption of nutrients from the gastrointestinal tract.
maximinesee histamine dihydrochloride.
medicaidin the United States, a program that is funded by federal and state governments that pays for medical care for those who can
medicarein the United States, a program that pays for certain health care expenses for people 65 and older.